Robert Loewe's Biography

Robert Loewe, Chief Executive Officer, Genewake

Dr. Robert Loewe is the founder of GeneWake, and has been chief executive officer since the company´s inception in 2009. He is a molecular biologist with over 13 years experience in personalized medicine. Past projects included therapy outcome prediction in breast cancer patients (CellControl), cytotoxic sera treatment for individual patients (Megamedics), microarray analysis of tumor samples and market evaluation (Infineon Biosciences), enzymatic treatment of cancer patients (Medical Enzymes) and companion diagnostic development for multiple compounds for oncology (Roche Diagnostics). His company GeneWake is focusing on personalized medicine, pharmacogenomics and companion diagnostics. He utilizes multiple techniques to develop new tests and formats to improve patient outcome. Special field of interest is here qPCR and NGS to establish practical approaches for clinical routine. The German Federal Ministry of Education and Research currently funds two of his novel methods used for patient stratification.